Lantern Pharma (NASDAQ: LTRN) | Q1/2023 Operating & Financial Results Conference Call
- Published Jun 09, 2023
- Biotech & Healthcare
- Market News
[social_share_button themes='theme8']
YOUR GUIDE TO STAYING INFORMED IN THE MARKETS
Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!